One more in a series of posts by the Usana insider on a Yahoo message board: on august 10 when we first got news of the nasd delisting and bought 130,000 shares through d a davidson. we spent exactly 4,793,659.00 […]
Helen Malmgren has written another article on Usana Health Sciences. The article says that Mr. Ladd MacNamara (not Dr.) sent NBR a letter regarding their reporting of his Usana situation:
CNET News.com By Erica Ogg An internal probe finds the PC maker fudged the timing of expenses and payments on its balance sheets. So where does it go from here? Though Dell has finished an internal investigation into its accounting […]
Bert Fingerhut, a former Wall Street broker, is going to prison for two year for illegally obtaining stock in 65 public offerings by banks and profiting over $11 million from it. One such instance related to stock in Bank Mutual, […]
Reported to the public via a press release: USANA Health Sciences Inc. (NASDAQ:USNA – News) today announced that the company has received an automated notice from the NASDAQ indicating that the Company’s recent quarterly report on form 10-Q is considered […]
From the 8-K filed today: Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On August 10, 2007, the Company received a Nasdaq Staff Determination letter indicating that the Company fails […]
From The BizOp News blog by Michael Webster, Tri Energy: Massive Affinity Fraud And Ponzi Scheme. A U.S. District Judge in California ruled against Tri Energy Inc., H&J Energy Company Inc., and several others last week. The defendants are permanently […]
This week’s Wisconsin Law Journal column takes a look at the Sarbanes-Oxley Act of 2002, which was put into law five years ago. The legislation has done some good things, but many have significant criticisms of it. The law was […]
It’s been five years since the passage of the Sarbanes-Oxley Act of 2002, and for many of us, it seems like it’s been around for a lifetime. While the intent behind the legislation was good, it has been extremely costly, […]
Usana’s most recent 10-Q filing with the Securities and Exchange Commission was NOT reviewed by an independent auditor. From NASDAQ’s FAQ: What are the repercussions if my company’s auditors did not review the quarterly financial statements as required under SAS […]


